Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (421-430 of 425) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 425 results.
Atherosclerosis. Supplements|May 21, 2014
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practiceNaveed A Sattar, Henry Ginsberg, Kausik Ray, et al.
Expert Opinion on Drug Safety|April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Archivos De Cardiologia De Mexico|June 29, 2021
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)Carlos I Ponte-Negretti, Fernando S Wyss, Daniel Piskorz, et al.
Archives of Medical Science : AMS|April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
Pageof 43

Showing results (421-430 of 425) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 425 results.
Atherosclerosis. Supplements|May 21, 2014
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practiceNaveed A Sattar, Henry Ginsberg, Kausik Ray, et al.
Expert Opinion on Drug Safety|April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Archivos De Cardiologia De Mexico|June 29, 2021
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)Carlos I Ponte-Negretti, Fernando S Wyss, Daniel Piskorz, et al.
Archives of Medical Science : AMS|April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
Pageof 43